(435) 292-5548
 Medicare News
Home  ›  Prescription Assistance  ›  Savaysa

Blood Thinners · Heart & Blood Pressure

Savaysa Assistance Programs & Grants

Assistance information last verified: August 2026

AltaMedicare is an independent Medicare agency in Alpine, Utah, founded by Bret Swope, a licensed Medicare agent. We provide educational, no-pressure help comparing Medicare Advantage, Medigap (Medicare Supplement), and Part D at no cost, serving the entire state of Utah. Call or text (435) 292-5548.

Manufacturer programs, charitable grants and Medicare routes for Savaysa (edoxaban) — each checked on its official source.

Can I get help paying for Savaysa?

No — and this is the clearest negative finding in this whole section. Daiichi Sankyo publishes no savings card, no copay program and no patient assistance program covering Savaysa; its assistance program covers four oncology medicines only. There is no generic edoxaban and no Medicare-negotiated price. The single charitable fund that lists Savaysa was closed.

  • No manufacturer cost support at all: savaysa.com has no savings, copay or assistance section — only clinical information, FAQs and prescribing documents.
  • Daiichi Sankyo's AccessCentral4U program covers DATROWAY, ENHERTU, TURALIO and VANFLYTA — all oncology products. Savaysa is not among them, and daiichisankyo.us/patient-assistance returns a 404.
  • No generic: DailyMed labels exactly one edoxaban product.
  • Not a Medicare-negotiated drug — while Eliquis and Xarelto have had negotiated prices in effect since January 1, 2026, and Pradaxa has nineteen generic labelers.
  • Charitable grants: TotalAssist's Stroke fund lists "Savaysa (Edoxaban)" and was closed ($1,000 guaranteed / $1,500 maximum). HealthWell runs no anticoagulation fund at all, and neither does Good Days.
  • What remains: Extra Help, the $2,100 Part D cap, the Medicare Prescription Payment Plan, a formulary exception, and a conversation with your cardiologist about the alternatives — bearing in mind Savaysa's kidney-function limits.

None of the 5 programs we checked for Savaysa were accepting new applications when verified in August 2026 — see the alternatives below.

About Savaysa (edoxaban)

Savaysa is a once-daily anticoagulant — a blood thinner that slows the clotting proteins in blood — used for atrial fibrillation and for clots in the legs and lungs. It is the least-supported medication on this site: Daiichi Sankyo publishes no savings card, no copay program and no patient assistance program for it, there is no generic, and the one charitable fund that lists it was closed. This page tells you that plainly, because knowing it saves you an afternoon of looking.

Approved uses

  • Reducing the risk of stroke and systemic embolism in people with non-valvular atrial fibrillation, subject to the kidney-function limits in the label
  • Treating deep vein thrombosis and pulmonary embolism after 5 to 10 days of an injectable blood thinner

Manufacturer: Daiichi Sankyo

Why Savaysa can be expensive on Medicare

Savaysa is a brand-only tablet with no generic — DailyMed labels exactly one edoxaban product — taken indefinitely once started, and Part D plans place it on a brand tier. What makes its cost picture unusually hard is not the price but the absence of everything that normally softens it: no manufacturer copay card, no manufacturer patient assistance program, no negotiated Medicare price and no generic. Among the direct oral anticoagulants, Savaysa is the only one with none of those.

Medicare coverage context

Savaysa is a tablet you take yourself, so Medicare covers it under Part D or a Medicare Advantage drug plan, usually on a brand tier. It is not a Medicare-negotiated drug: CMS's selected-drug and Maximum Fair Price file has no Savaysa or edoxaban row for 2026, 2027 or 2028. The comparison matters here more than on most pages. Eliquis and Xarelto were both selected in the first negotiation cycle and have had negotiated prices in effect since January 1, 2026; Pradaxa is available as a generic from nineteen labelers. Savaysa has neither route. So for a Medicare beneficiary the tools that remain are the general ones — the $2,100 Part D out-of-pocket cap in 2026, Extra Help, the Medicare Prescription Payment Plan, and a plan comparison in the fall — plus a genuine clinical conversation about whether one of the other anticoagulants would serve you as well. One important note on that conversation: Savaysa's label carries kidney-function limits that the others do not share in the same form, so this is a decision for your prescriber and not a swap to make on cost grounds alone.

Check typical Part D coverage · Estimate your drug costs · Compare Part D drug plans

Savaysa assistance options at a glance

Every program we checked, what kind of help it is, whether people with Medicare can use it, and its status when we verified it. A medication being listed by a program is not the same as the program accepting applications.

About the income limits below: Income limits can differ between assistance programs even when both describe their eligibility as the same percentage of the federal poverty level. The dollar limits shown here come from each program's own published income table, and each program decides which year's poverty guidelines that table is built from and when it takes effect. Treat the figures as belonging to the program they are listed under — they are not interchangeable, and only the program can tell you which table it is applying to your application today.

Savaysa assistance programs compared
ProgramType of helpPeople with MedicareStatus (August 2026)
Daiichi Sankyo patient assistance — Savaysa not covered Manufacturer patient assistance not stated No program found
Savaysa savings or copay card — none found Commercial copay / savings card not stated No program found
TotalAssist — Stroke fund Charitable grant may apply Closed to new applicants
HealthWell Foundation — no applicable fund Charitable grant may apply No program found
Good Days — no applicable fund Charitable grant not stated No program found
Medicare Extra Help (Part D Low-Income Subsidy) Government program may apply Accepting applications

Manufacturer programs from Daiichi Sankyo

A patient assistance program (free or low-cost drug by income) is not the same as a copay card (a commercial discount that usually excludes Medicare). Both are listed so you can see which one applies to you.

Manufacturer patient assistance

Daiichi Sankyo patient assistance — Savaysa not covered

Daiichi Sankyo

No program found Medicare: not stated

Status: Daiichi Sankyo's patient support offering on August 26, 2026 is AccessCentral4U, and it covers four medicines: DATROWAY, ENHERTU, TURALIO and VANFLYTA — all oncology products. Savaysa is not among them. The company also participates in the Partnership for Prescription Assistance. Separately, daiichisankyo.us/patient-assistance returned HTTP 404 on the checked date.

An honest negative, and the most important fact on this page. Daiichi Sankyo does run patient assistance, but only for its oncology medicines. Do not spend time on an application for Savaysa — there is no program to apply to.

If you have Medicare: Not applicable — Savaysa is not part of any Daiichi Sankyo assistance program, so none states a Medicare rule for it. This is a straightforward absence rather than an exclusion, and it is not a case of a source being unreadable: the company's program page lists its covered medicines explicitly and Savaysa is not one.

How to apply

Not applicable for Savaysa. If Daiichi Sankyo adds it, it would appear on the patient support programs page cited here.

Daiichi Sankyo patient support programs →

Commercial copay / savings card

Savaysa savings or copay card — none found

Daiichi Sankyo

No program found Medicare: not stated

Status: There is no savings, co-pay or cost-support section anywhere on savaysa.com. On August 26, 2026 the site's sections were Home, SAVAYSA for AFib, About AFib, Living with AFib, SAVAYSA for DVT/PE, About DVT/PE, Living with DVT/PE, FAQs, Important Safety Information, Prescribing Information and the Medication Guide. Nothing about cost appears on any of them.

A second honest negative. Most brand medicines on this site have at least a commercial copay card. Savaysa has none — which is unusual enough that people assume they have simply failed to find it. They have not.

If you have Medicare: Academic, since no card exists. Worth saying anyway because it is the usual next question: manufacturer copay cards are closed to Medicare across the board under federal anti-kickback rules, so even if Daiichi Sankyo introduced one it would not be a route for a Medicare beneficiary. The absence costs Medicare readers nothing; it costs commercially insured readers a great deal.

How to apply

Not applicable. If Daiichi Sankyo introduces a savings program it would appear on savaysa.com, which is cited here.

SAVAYSA patient site →

Charitable grants for Savaysa

One fund lists Savaysa and it was closed. TotalAssist's Stroke fund names both "Savaysa (Edoxaban)" and "Lixiana (Edoxaban)" on its approved-medication list, paying $1,000 guaranteed up to $1,500 when open, and it was shut on August 26, 2026. HealthWell runs no atrial fibrillation, stroke, deep vein thrombosis, pulmonary embolism or anticoagulant fund at all, and Good Days has none either. That single closed fund is the entire charitable picture for this medication, and unlike most pages on this site there is no manufacturer program sitting behind it. Set the TotalAssist alert today. Then put your real effort into Extra Help, the Medicare Prescription Payment Plan, and a conversation with your cardiologist about the alternatives — because for Savaysa those are not fallbacks, they are the plan.

Charitable grant

TotalAssist — Stroke fund

Patient Advocate Foundation · Stroke

Closed to new applicants Medicare: may apply

Status: Closed to new applicants on August 26, 2026, with a $1,000 guaranteed and $1,500 maximum award. TotalAssist has no waitlist, so the notification sign-up is what gets you in when it reopens.

"Savaysa (Edoxaban)" and "Lixiana (Edoxaban)" are both named on the Stroke fund's approved-medication list, alongside every other oral anticoagulant. It is the only applicable fund on any of the three foundations, and it was closed.

If you have Medicare: This fund requires government-insured coverage — Medicare, Medicaid or TRICARE — that covers your qualifying expenses. Medicare beneficiaries are eligible when it is open. Given that there is no manufacturer route at all for Savaysa, this alert is one of the few concrete actions available, and it is worth setting today rather than when you next need a refill.

What it can cover: When open: $1,000 guaranteed award and up to $1,500 maximum for medication copays, coinsurance, deductibles and health-insurance premiums. One grant per condition.

Who may qualify

  • Confirmed stroke diagnosis, in treatment, starting within 60 days, or treated in the past 6 months
  • Government-insured coverage (Medicare, Medicaid or TRICARE) that covers your qualifying expenses
  • Household income at or below 500% of the federal poverty level, adjusted for your regional cost-of-living index
  • Confirmed diagnosis matching the fund, and in treatment (or starting within 60 days, or treated in the past 6 months)
  • Legal U.S. resident receiving treatment in the U.S. or a U.S. territory

What the application asks for

  • Contact information and Social Security number (or alien number)
  • Annual household income (for pre-screening; proof of income due within 30 days of approval)
  • Health insurance carrier, plan type, policy ID and group number; Medicare supplement or secondary insurance if you have one
  • Copay or coinsurance amounts
  • Your provider's name and contact information, diagnosis (exact date if within 6 months), prescribed medications and treatment plan

How to apply

Sign up for fund notifications (text, email or automated call) at totalassist.org/notify. When a fund opens: You (the patient) apply online — it takes about 15 minutes and you learn immediately whether you are approved — or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis and treatment plan directly with your provider and verifies income automatically; you have 30 days after approval to provide proof of income.

Get notified when a TotalAssist fund opens → 866-512-3861

Charitable grant

HealthWell Foundation — no applicable fund

HealthWell Foundation

No program found Medicare: may apply

Status: HealthWell's published disease-fund list on August 26, 2026 contained no atrial fibrillation, stroke, deep vein thrombosis, pulmonary embolism or anticoagulant fund of any kind.

An honest negative. HealthWell does open new funds as well as reopening old ones, so the disease-funds list is worth an occasional look — but there is nothing to apply to today.

If you have Medicare: HealthWell accepts Medicare beneficiaries for the diseases it covers. It covers no diagnosis that would apply to Savaysa, so no Medicare rule is engaged.

How to apply

Not applicable today. The disease-funds page lists every fund HealthWell runs and its status.

HealthWell disease funds → (800) 675-8416

Charitable grant

Good Days — no applicable fund

Good Days

No program found Medicare: not stated

Status: Good Days' published disease list on August 26, 2026 contained 57 programs and none was atrial fibrillation, stroke or any blood-clot condition.

The third honest negative in a row. Checked so you do not spend time on a foundation that has no fund for you.

If you have Medicare: Good Days accepts Medicare beneficiaries for the diseases it covers, but it covers no diagnosis that applies to Savaysa.

How to apply

Not applicable today. The diseases-covered page shows every fund Good Days runs.

Good Days diseases covered →

How to apply for Savaysa assistance

  1. Step 1 — Find the applicable assistance program

    For Savaysa on Medicare in August 2026 the honest first step is to rule out the routes people expect to exist, because none of them do:

    • There is no Daiichi Sankyo program for Savaysa, no savings card and no generic. Do not spend time looking.
    • Limited income and resources → Medicare Extra Help through Social Security. This is the most valuable route available for this medication.
    • Enrol in the Medicare Prescription Payment Plan to spread the cost across the year.
    • Stroke diagnosis → set an alert on the TotalAssist Stroke fund (closed when checked).
    • Ask your cardiologist whether Eliquis, Xarelto or generic dabigatran would suit you — but read the kidney-function note below before assuming a swap is straightforward.
    • Compare Part D plans in the fall: with no other lever available, tier placement is doing more work here than usual.

  2. Step 2 — Check whether applications are currently open

    There is no manufacturer application to check for Savaysa. What can change is fund status.

    • Daiichi Sankyo: the patient support programs page lists its covered medicines — check whether Savaysa has been added since this page was verified.
    • TotalAssist: the Stroke fund page shows "Open" or "Closed" and the current award amounts.
    • HealthWell: worth re-checking the disease-funds list occasionally, since HealthWell opens new funds as well as reopening old ones.

  3. Step 3 — Check eligibility

    Only two things here have eligibility rules that could apply to you:

    • Extra Help: income below about $23,940 a year for one person or $32,460 for a couple, and countable resources limited to $18,090 or $36,100 in 2026.
    • TotalAssist (when open): government insurance covering Savaysa; income at or below 500% FPL adjusted for your regional cost-of-living index; a confirmed stroke diagnosis in treatment, starting within 60 days, or treated in the past 6 months.
    • Medicare Prescription Payment Plan: no income test — it is open to any Part D enrollee, and it spreads costs rather than lowering them.
    • Daiichi Sankyo: not applicable, because Savaysa is not on any of its programs.

  4. Step 4 — Gather your information

    Whichever route you take, these are what will be asked for:

    • Medicare card and your Part D or Medicare Advantage drug-plan card, with policy ID and group number.
    • Your diagnosis and its date — atrial fibrillation, deep vein thrombosis, pulmonary embolism or stroke. TotalAssist needs the exact date if it was within the past 6 months.
    • Your Savaysa strength — 15 mg, 30 mg or 60 mg.
    • Your most recent kidney function result, if you have it. It is relevant to any conversation about alternatives, because Savaysa's label sets kidney-function limits.
    • Household size and annual household income, plus proof.

  5. Step 5 — Complete the application

    Who fills out what:

    • Extra Help: you (or someone helping you) apply free through Social Security — online, by phone on 1-800-772-1213, or at an office. There is never a fee.
    • TotalAssist (when open): you apply online in about 15 minutes or by phone on 866-512-3861; Patient Advocate Foundation verifies the diagnosis with your provider.
    • Medicare Prescription Payment Plan: you opt in through your Part D plan.
    • Formulary exception: your prescriber's office submits it to your plan.

  6. Step 6 — Submit and wait for a determination

    What to expect:

    • Extra Help: Social Security notifies you by mail; your Part D plan then applies the lower copays.
    • TotalAssist (when open): an immediate online decision, with proof of income due within 30 days of approval.
    • Formulary exception: plans generally must respond within a set timeframe; your prescriber's office can tell you what to expect.

  7. Step 7 — If the program is closed or you don't qualify

    Never stop or ration an anticoagulant to save money. With no manufacturer route available, these are the real options:

    • Ask your cardiologist about the alternatives — but ask properly. Eliquis and Xarelto have Medicare-negotiated prices in effect, and generic dabigatran costs a fraction of any of them. However, Savaysa's label sets kidney-function limits that shape who it is prescribed for in the first place, so if you were put on Savaysa specifically there may be a clinical reason. Bring your kidney function results to the conversation.
    • Apply for Extra Help even if you assume you earn too much. For this medication it is the largest lever you have.
    • Enrol in the Medicare Prescription Payment Plan — it does not lower the total but it stops a brand-tier bill landing all at once.
    • Ask your prescriber's office about a formulary or tier exception.
    • Compare Part D plans carefully in the fall. With no generic, no negotiated price and no manufacturer help, your plan's tier placement for Savaysa is the single biggest variable in what you pay.
    • Call AltaMedicare — this is exactly the situation where a plan comparison earns its keep, and we do it free.

What you'll need

Only items the programs above actually ask for. Gather these before you start.

  • Medicare card and your Part D or Medicare Advantage drug-plan card — plan name, member ID and group number
  • Prescription details — medication name, strength and dose; prescriber name, office phone and address
  • Diagnosis and date of diagnosis — TotalAssist needs the exact date if diagnosed within the past 6 months
  • Household size and annual household income — and proof — tax return, Social Security or pension statements, or pay stubs
  • Your Savaysa strength — 15 mg, 30 mg or 60 mg — the dose depends partly on kidney function and body weight
  • Your most recent kidney function result — Savaysa's label sets kidney-function limits, so this is central to any conversation about switching anticoagulants

If assistance is unavailable

A closed fund or a denial is not the end of the road. Check these next:

  1. Because Daiichi Sankyo has no assistance program and no savings card for Savaysa, and there is no generic, the first conversation is clinical: ask your cardiologist whether Eliquis, Xarelto or generic dabigatran suits you, bringing your kidney function results, since Savaysa's label sets kidney-function limits.
  2. Enrol in the Medicare Prescription Payment Plan. With no other manufacturer or generic route, spreading the cost across the year is one of the few practical steps available. Medicare.gov
  3. Sign up for TotalAssist fund notifications so you hear the moment a Savaysa fund reopens — there is no waitlist or queue, so speed matters. TotalAssist notifications
  4. Sign up for HealthWell fund alerts for the same reason; HealthWell says closed funds reopen as funding is replenished. HealthWell disease funds
  5. Check Medicare Extra Help — it does not depend on a fund balance and lowers the cost of every covered drug, not just this one. Medicare Extra Help explained
  6. Ask your doctor's office — many practices have staff who handle assistance applications routinely and can request a formulary exception or a lower-cost alternative.
  7. Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments (it does not lower the total). Medicare.gov
  8. Compare Part D and Medicare Advantage drug plans during the fall enrollment period — the tier and cost-sharing for Savaysa differ from plan to plan. Compare Part D plan options

Could Medicare Extra Help reduce your Savaysa costs?

Extra Help is not a grant for Savaysa. It is a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription — so it is worth checking even when a charitable fund is closed, because it does not depend on fund balances.

Extra Help matters more for Savaysa than for almost any other medication on this site, because it is the only income-based help that exists for it. There is no manufacturer program to weigh it against, no generic to switch to and no negotiated price to wait for — so there is no conflict, no sequencing question and nothing to lose. If your income and resources are limited, apply, and apply even if you assume you earn too much: the limits are higher than most people expect. With full Extra Help a covered brand-name drug costs about $12.65 in 2026, which against brand-tier cost-sharing on a daily anticoagulant is the single largest difference available to you.

In 2026, people with full Extra Help generally pay no more than $12.65 for a covered brand-name drug. Income must be below about $23,940 a year for one person ($32,460 for a couple) and countable resources under $18,090 ($36,100 for a couple). Apply free through Social Security — online, by phone at 1-800-772-1213, or in person — and never pay anyone to apply for you.

Extra Help explained · Medicare Savings Programs · Estimate your drug costs · Free prescription cost review

Government program

Medicare Extra Help (Part D Low-Income Subsidy)

Medicare / Social Security Administration

Accepting applications Medicare: may apply

Status: Year-round federal program (figures for 2026)

Not a grant for one drug — a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription.

If you have Medicare: For people with Medicare Part D or a Medicare Advantage drug plan who have limited income and resources.

What it can cover: Part D premium and deductible (often to $0) and reduced copays — generally no more than $12.65 for a covered brand-name drug in 2026 with full Extra Help.

Who may qualify

  • Income below 150% of the federal poverty level — about $23,940 a year for one person or $32,460 for a married couple in 2026.
  • Countable resources (savings, investments — not your home or car) limited to $18,090 for an individual or $36,100 for a married couple living together in 2026 (Medicare.gov figures, which include a burial-expense allowance).
  • Automatic if you have Medicaid, Supplemental Security Income (SSI), or a Medicare Savings Program.

What the application asks for

  • Social Security number and Medicare number
  • Income (Social Security, pensions, wages) for you and a spouse you live with
  • Value of savings, investments and other countable resources

How to apply

You (or someone helping you) apply free through Social Security — online, by phone, or at a Social Security office. There is never a fee to apply.

Apply for Extra Help at SSA.gov → 1-800-772-1213

Key terms on this page

Patient assistance program (PAP)
A manufacturer program that provides its medication free or at low cost to people who meet income and insurance rules. Many PAPs accept Medicare Part D enrollees; each sets its own criteria.
Copay card / savings card
A manufacturer discount for commercially insured patients. Federal anti-kickback rules mean these cards generally cannot be used with Medicare, Medicaid or other government insurance.
Charitable copay grant
Money from a nonprofit foundation (for example HealthWell or Patient Advocate Foundation) that pays eligible copays or coinsurance for a specific diagnosis. A drug can be listed while the fund is closed to new applicants.
Federal poverty level (FPL)
A federal income measure that assistance programs use as a yardstick — "300% of FPL", "500% of FPL". The percentage is a rule, but the dollar figure behind it comes from a table each program publishes itself, built on a chosen year of the HHS poverty guidelines. Two programs can quote the same percentage in the same year and still list different dollar limits; compare each program against its own table, not against another program.
Medicare Extra Help
The Part D Low-Income Subsidy: a Medicare program that lowers or eliminates Part D premiums, deductibles and copays for beneficiaries with limited income and resources. You apply through Social Security.
Maximum Fair Price (MFP)
The price Medicare negotiated for a selected drug under the Medicare Drug Price Negotiation Program. It applies to Part D plans, not to the pharmacy cash price, and it lowers what plans and enrollees pay for that drug.

Related medication assistance guides

Eliquis Assistance & Grants apixaban Xarelto Assistance & Grants rivaroxaban Pradaxa Assistance & Grants dabigatran etexilate Brilinta Assistance & Grants ticagrelor All prescription assistance Directory & program finder
Common Questions

Savaysa assistance FAQ

Does Medicare cover Savaysa?
Yes — Medicare Part D and Medicare Advantage drug plans generally cover Savaysa, usually on a brand tier. Part D out-of-pocket costs are capped at $2,100 in 2026. If your income and resources are limited, Medicare Extra Help can bring a covered brand-name copay to about $12.65 — which for this particular medication is the most valuable help available, because there is nothing else.
Is there a Savaysa patient assistance program or savings card?
No, to both. This is not a case of a source being hard to read: savaysa.com has no savings, co-pay or cost-support section anywhere on it — the site carries only clinical information, FAQs and prescribing documents. And Daiichi Sankyo's patient assistance program, AccessCentral4U, covers four oncology medicines — DATROWAY, ENHERTU, TURALIO and VANFLYTA — with Savaysa in none of them. The company's /patient-assistance page returns a 404. There is genuinely nothing to apply for.
Is there a generic for Savaysa?
No. DailyMed lists exactly one labelled edoxaban product, Daiichi Sankyo's Savaysa. This is what makes Savaysa unusual among the direct oral anticoagulants: Pradaxa has generic dabigatran from nineteen different labelers, and Eliquis and Xarelto both have Medicare-negotiated prices. Savaysa has neither a generic nor a negotiated price.
Should I switch to a different blood thinner to save money?
That is a fair question to raise with your cardiologist, but it is a clinical decision and not one to make on price alone. Eliquis and Xarelto have had Medicare-negotiated prices in effect since January 1, 2026, and generic dabigatran costs a fraction of any brand. However, Savaysa's label carries kidney-function limits that shape who it is prescribed for, so if you were specifically put on Savaysa there may be a reason. Bring your most recent kidney function results to the appointment and ask directly. Never stop or ration an anticoagulant while you wait for that conversation.
Is Savaysa part of Medicare drug price negotiation?
No. CMS's selected-drug and Maximum Fair Price file has no Savaysa or edoxaban row for initial price applicability year 2026, 2027 or 2028. Two other direct oral anticoagulants were selected in the very first cycle and have had negotiated prices in effect since January 1, 2026 — Eliquis and Xarelto. Your Savaysa cost is set entirely by your plan's tier and cost-sharing, which is why a careful plan comparison in the fall matters more for this medication than for most.
Is there a charitable grant for Savaysa right now?
Not when we checked on August 26, 2026. TotalAssist lists "Savaysa (Edoxaban)" on its Stroke fund and that fund was closed, with a $1,000 guaranteed and $1,500 maximum award. It is the only fund on any of the three foundations that covers this medication — HealthWell runs no anticoagulation fund at all, and neither does Good Days. Set the TotalAssist alert, because with no manufacturer program behind it, that one fund reopening is a more significant event for Savaysa than it would be for most drugs. See all prescription assistance options.

Sources

Related resources

Assistance information last verified August 2026. Program details — fund status, eligibility, prices, phone numbers — change often; confirm with each program before applying. AltaMedicare does not administer, fund or approve any assistance program. Not medical advice.

Having trouble figuring out your prescription costs?

Bret can help you understand your Medicare prescription coverage and where to look for Savaysa assistance — free, no pressure. We don't award grants or decide eligibility; the programs above do. We help you find and apply to the right ones.

Text Bret About Savaysa Call (435) 292-5548